Selected publications
Sande NK, Bøyesen P, Aga AB, Hammer HB, Flatø B, Roth J, Lilleby V. Development and reliability of a novel ultrasonographic joint-specific scoring system for synovitis with reference atlas for patients with juvenile idiopathic arthritis. RMD Open. 2021 Apr;7(2):e001581. doi: 10.1136/rmdopen-2021-001581.
Tollisen A, Flatø B, Selvaag AM, Aasland A, Ingebrigtsen T, Sagen J, Lerdal A. Treatment Satisfaction With and Adherence to Disease-Modifying Antirheumatic Drugs in Adult Patients With Juvenile Idiopathic Arthritis. Arthritis Care Res (Hoboken). 2021 Feb;73(2):221-231. doi: 10.1002/acr.24113.
Lillegraven S*, Sundlisæter NP*, Aga A-B*, Sexton J, Olsen JC, Fremstad H, Spada C, Madland TM, A Høili CA, Bakland G, Lexberg Å, Hansen IJW, Hansen IM, Haukeland H, Ljoså M-KA, Moholt E, Uhlig T, Solomon DH, van der Heijde D, Kvien TK, Haavardsholm EA, *shared first authorship. Effect of Half-Dose vs Stable-Dose Conventional Synthetic Disease-Modifying Antirheumatic Drugs on Disease Flares in Patients With Rheumatoid Arthritis in Remission. The ARCTIC REWIND Randomized Clinical Trial. JAMA. 2021;325(17):1755-1764. doi:10.1001/jama.2021.4542
Holten K, Paulshus Sundlisater N, Lillegraven S, Sexton J, Nordberg LB, Moholt E, Hammer HB, Uhlig T, Kvien TK, Haavardsholm EA, Aga AB. Fatigue in patients with early rheumatoid arthritis undergoing treat-to-target therapy: predictors and response to treatment. Ann Rheum Dis. 2021 Aug 13:annrheumdis-2021-220750. doi: 10.1136/annrheumdis-2021-220750. Epub ahead of print.
Tollisen A, Selvaag AM, Aasland A, Lerdal A, Flatø B. Longitudinal Health Status from Early Disease to Adulthood and Associated Prognostic Factors in Juvenile Idiopathic Arthritis. J Rheumatol. 2019 Oct;46(10):1335-1344. doi: 10.3899/jrheum.180948. Epub 2019 Mar 15.
Flato B, Rygg M, Nordal EB, Røisland M, Ødegård HB, Hoftun GB, Songstad NT, Consolaro A, Bovis F, Ruperto N; Paediatric Rheumatology International Trials Organisation (PRINTO). The Norwegian version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR). Rheumatol Int. 2018 Apr;38(Suppl 1):291-298. doi: 10.1007/s00296-018-3963-y. Epub 2018 Apr 7.
Østergaard M, Peterfy CG, Bird P, Gandjbakhch F, Glinatsi D, Eshed I, Haavardsholm EA, Lillegraven S, Bøyesen P, Ejbjerg B, Foltz V, Emery P, Genant HK, Conaghan PG. The OMERACT Rheumatoid Arthritis Magnetic Resonance Imaging (MRI) Scoring System: Updated Recommendations by the OMERACT MRI in Arthritis Working Group. J Rheumatol. 2017 Nov;44(11):1706-1712. doi: 10.3899/jrheum.161433. Epub 2017 Aug 15.
Hetlevik SO, Flatø B, Rygg M, Nordal EB, Brunborg C, Hetland H, Lilleby V. Long-term outcome in juvenile-onset mixed connective tissue disease: a nationwide Norwegian study. Ann Rheum Dis. 2017 Jan;76(1):159-165. doi: 10.1136/annrheumdis-2016-209522. Epub 2016 Jun 9.
Haavardsholm EA, Aga AB, Olsen IC, Lillegraven S, Hammer HB, Uhlig T, Fremstad H, Madland TM, Lexberg ÅS, Haukeland H, Rødevand E, Høili C, Stray H, Noraas A, Hansen IJ, Bakland G, Nordberg LB, van der Heijde D, Kvien TK. Ultrasound in management of rheumatoid arthritis: ARCTIC randomised controlled strategy trial. BMJ. 2016 Aug 16;354:i4205. doi: 10.1136/bmj.i4205.
Selvaag AM, Aulie HA, Lilleby V, Flatø B. Disease progression into adulthood and predictors of long-term active disease in juvenile idiopathic arthritis. Ann Rheum Dis. 2016 Jan;75(1):190-5. doi: 10.1136/annrheumdis-2014-206034.